Literature DB >> 26485652

Correction: Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.

Chun-Yan Yeung, Wai-Tao Chan, Chun-Bin Jiang, Mei-Lien Cheng, Chia-Yuan Liu, Szu-Wen Chang, Jen-Shiu Chiang Chiau, Hung-Chang Lee.   

Abstract

Entities:  

Year:  2015        PMID: 26485652      PMCID: PMC4613823          DOI: 10.1371/journal.pone.0141402

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The captions for Figs 5 and 6 are incorrectly switched. The caption for Fig 5 should be the caption for Fig 6, and the caption for Fig 6 should be the caption for Fig 5. Please see the corrected captions here. Fig 5. A: Representative histological sections of jejunum showing the goblet cells with haematoxylin and eosin stain in mice on day 5 challenged with 5-FU (IP). They were fed with probiotics (Lcr35orLaBi) or saline. The arrows indicated goblet cells. The image acquisition phase was done with a 20x magnification objective. Scale bar = 50μm. B: Jejunal goblet cells after staining were counted. Values were represented as mean±SEM and were analyzed using one-way ANOVA. Fig 6. Up-regulations of IL-6, IL-1βand TNF-αin mucositis mice were followed after injection with 5-FU. Mucositis mice were fed with (+) or without (−) probiotics. Gene expressions of IL-6, IL-1βand TNF-αwere determined by Q-PCR (A) jejunum tissue (B) colon tissue. Induction of cytokine expressions were presented as RQ compared to 18sRNA housekeeping gene expression. The data with different superscripted letters are significantly different based on the one-way ANOVA.
  1 in total

1.  Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.

Authors:  Chun-Yan Yeung; Wai-Tao Chan; Chun-Bin Jiang; Mei-Lien Cheng; Chia-Yuan Liu; Szu-Wen Chang; Jen-Shiu Chiang Chiau; Hung-Chang Lee
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  1 in total
  5 in total

Review 1.  Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

Authors:  Concetta Panebianco; Angelo Andriulli; Valerio Pazienza
Journal:  Microbiome       Date:  2018-05-22       Impact factor: 14.650

Review 2.  Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients.

Authors:  H R Wardill; K R Secombe; R V Bryant; M D Hazenberg; S P Costello
Journal:  EBioMedicine       Date:  2019-03-30       Impact factor: 8.143

3.  Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP.

Authors:  Rodrigo Carvalho; Aline Vaz; Felipe Luiz Pereira; Fernanda Dorella; Eric Aguiar; Jean-Marc Chatel; Luis Bermudez; Philippe Langella; Gabriel Fernandes; Henrique Figueiredo; Aristóteles Goes-Neto; Vasco Azevedo
Journal:  Sci Rep       Date:  2018-10-10       Impact factor: 4.379

Review 4.  Probiotics in the Treatment of Colorectal Cancer.

Authors:  Robert Hendler; Yue Zhang
Journal:  Medicines (Basel)       Date:  2018-09-07

5.  Correlation between changes in gut flora and serum inflammatory factors in children with noninfectious diarrhea.

Authors:  Fangfang Qin; Haibo Wu; Xiumin Li; Jie Han
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.